Current disease status-In remission-Remission after recurrent disease Posts on Medivizor
Navigation Menu

Current disease status-In remission-Remission after recurrent disease Posts on Medivizor

Stem cell transplant in patients in second complete remission with core binding factor acute myeloid leukemia.

Stem cell transplant in patients in second complete remission with core binding factor acute myeloid leukemia.

Posted by on Sep 30, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the outcomes of allogeneic transplantation in patients with core-binding factor acute myeloid leukemia in second complete remission.   This study concluded that transplant was effective in a large proportion of these patients.   Some background Core binding factor acute myeloid...

Read More

Searching for patients with leukemia or lymphoma to test modified stem cell transplants donated by relatives

Posted by on Sep 20, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This trial is examining the effectiveness of modified stem cell transplants (SCT) donated by patient relatives, which have certain immune cells removed to prevent transplant rejection in patients with leukemia and lymphoma. The main outcome will be the maximum dose of SCT that can be given safely and is effective. This study is...

Read More

How can cytogenetic-risk status affect the outcome of cell transplants for acute myeloid leukaemia patients?

How can cytogenetic-risk status affect the outcome of cell transplants for acute myeloid leukaemia patients?

Posted by on Oct 1, 2017 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the post-hematopoietic (stem) cell transplant outcomes for older patients with AML in their second complete remission. This study concluded that hematopoietic cell transplant is a good treatment option, especially for patients with favorable- or intermediate-cytogenetic risk status.  Some background...

Read More